Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-19-003657)

Filing Details

Accession Number:: 0000899243-19-003657
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2019-02-14 17:26:22
Reporting Period:: 2018-12-31

Accepted Time:: 2019-02-14 17:26:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1629137	Global Blood Therapeutics Inc.	GBT	Pharmaceutical Preparations (2834)	274825712

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1730866	Ann Lesley Calhoun	C/O Global Blood Therapeutics, Inc. 171 Oyster Point Blvd., Suite 300 South San Francisco CA 94080	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-01-31	510	$21.34	1,987	No	4	A	Direct
Common Stock	Disposition	2018-03-15	510	$54.68	1,477	No	4	S	Direct
Common Stock	Disposition	2018-07-03	187	$44.88	1,290	No	4	S	Direct
Common Stock	Disposition	2018-08-01	258	$43.52	1,032	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).